The Market LogEnter at least 2 characters. Company and ticker searches are not case-sensitive.

Company profile

Revolution Medicines, Inc. insider acquisitions

Company CIK 0001628171 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
RVMD · NasdaqRVMDW · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 23, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate
30-day company acquisitions grouped by security, category, original code, and currency.
Type / codeReported securityTransactionsKnown purchase valueMissing amounts
Exercise / conversionCode MCommon StockNon-derivative · Currency not specified1Not applicable0

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Sandler Alan B.Sandler Alan B.Anders JackAnders JackGOLDSMITH MARK AGOLDSMITH MARK ACislini JeffCislini JeffKelsey Stephen MichaelKelsey Stephen MichaelSandler Alan B. · September 29, 2026 · Exercise / conversion · Common StockAnders Jack · November 25, 2025 · Exercise / conversion · Common StockGOLDSMITH MARK A · November 25, 2025 · Exercise / conversion · Common StockGOLDSMITH MARK A · November 18, 2025 · Exercise / conversion · Common StockCislini Jeff · November 18, 2025 · Exercise / conversion · Common StockGOLDSMITH MARK A · November 12, 2025 · Exercise / conversion · Common StockAnders Jack · November 11, 2025 · Exercise / conversion · Common StockGOLDSMITH MARK A · November 12, 2025 · Gift received · Common StockGOLDSMITH MARK A · November 12, 2025 · Gift received · Common StockGOLDSMITH MARK A · November 7, 2025 · Exercise / conversion · Common StockGOLDSMITH MARK A · November 7, 2025 · Exercise / conversion · Common StockCislini Jeff · October 17, 2025 · Exercise / conversion · Common StockGOLDSMITH MARK A · October 17, 2025 · Exercise / conversion · Common StockGOLDSMITH MARK A · October 16, 2025 · Exercise / conversion · Common StockKelsey Stephen Michael · October 13, 2025 · Exercise / conversion · Common StockOct 13, 2025Sep 29, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

15 dated transactions · 5 of 5 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Sep 29, 2026Revolution Medicines, Inc.Common StockSandler Alan B.Exercise / conversion
Nov 25, 2025Revolution Medicines, Inc.Common StockAnders JackExercise / conversion
Nov 25, 2025Revolution Medicines, Inc.Common StockGOLDSMITH MARK AExercise / conversion
Nov 18, 2025Revolution Medicines, Inc.Common StockGOLDSMITH MARK AExercise / conversion
Nov 18, 2025Revolution Medicines, Inc.Common StockCislini JeffExercise / conversion
Nov 12, 2025Revolution Medicines, Inc.Common StockGOLDSMITH MARK AExercise / conversion
Nov 11, 2025Revolution Medicines, Inc.Common StockAnders JackExercise / conversion
Nov 12, 2025Revolution Medicines, Inc.Common StockGOLDSMITH MARK AGift received
Nov 12, 2025Revolution Medicines, Inc.Common StockGOLDSMITH MARK AGift received
Nov 7, 2025Revolution Medicines, Inc.Common StockGOLDSMITH MARK AExercise / conversion
Nov 7, 2025Revolution Medicines, Inc.Common StockGOLDSMITH MARK AExercise / conversion
Oct 17, 2025Revolution Medicines, Inc.Common StockCislini JeffExercise / conversion
Oct 17, 2025Revolution Medicines, Inc.Common StockGOLDSMITH MARK AExercise / conversion
Oct 16, 2025Revolution Medicines, Inc.Common StockGOLDSMITH MARK AExercise / conversion
Oct 13, 2025Revolution Medicines, Inc.Common StockKelsey Stephen MichaelExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Choose a company listing

Choose a current company listing to view its price history.

Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
Sandler Alan B.Chief Development Officer
Exercise / conversionCommon StockNon-derivative security · Code M6,00058.84Value: 353,040Currency not specifiedView ↗
Trade:
Anders JackChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M5,41817Value: 92,106Currency not specifiedView ↗
Trade:
GOLDSMITH MARK ASee Remarks · Director
Exercise / conversionCommon StockNon-derivative security · Code M60,0004.09Value: 245,400Currency not specifiedView ↗
Trade:
GOLDSMITH MARK ASee Remarks · Director
Exercise / conversionCommon StockNon-derivative security · Code M20,0004.09Value: 81,800Currency not specifiedView ↗
Trade:
Cislini JeffGeneral Counsel
Exercise / conversionCommon StockNon-derivative security · Code M13,38842.45Value: 568,320.6Currency not specifiedView ↗
Trade:
GOLDSMITH MARK ASee Remarks · Director
Exercise / conversionCommon StockNon-derivative security · Code M20,0004.09Value: 81,800Currency not specifiedView ↗
Trade:
Anders JackChief Financial Officer
Exercise / conversionCommon StockNon-derivative security · Code M10,00017Value: 170,000Currency not specifiedView ↗
Trade:
GOLDSMITH MARK ASee Remarks · Director
Gift receivedCommon StockNon-derivative security · Code G50,0000Value: 0Currency not specifiedView ↗
Trade:
GOLDSMITH MARK ASee Remarks · Director
Gift receivedCommon StockNon-derivative security · Code G50,0000Value: 0Currency not specifiedView ↗
Trade:
GOLDSMITH MARK ASee Remarks · Director
Exercise / conversionCommon StockNon-derivative security · Code M3,5214.09Value: 14,400.89Currency not specifiedView ↗
Trade:
GOLDSMITH MARK ASee Remarks · Director
Exercise / conversionCommon StockNon-derivative security · Code M26,4791.12Value: 29,656.48Currency not specifiedView ↗
Trade:
Cislini JeffGeneral Counsel
Exercise / conversionCommon StockNon-derivative security · Code M12,00036.57Value: 438,840Currency not specifiedView ↗
Trade:
GOLDSMITH MARK ASee Remarks · Director
Exercise / conversionCommon StockNon-derivative security · Code M10,0001.12Value: 11,200Currency not specifiedView ↗
Trade:
GOLDSMITH MARK ASee Remarks · Director
Exercise / conversionCommon StockNon-derivative security · Code M10,0001.12Value: 11,200Currency not specifiedView ↗
Trade: Exercise / conversionCommon StockNon-derivative security · Code M25,0004.73Value: 118,250Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →